One exception is alveolar soft part sarcoma (ASPS), which highly response to immune checkpoint inhibitors, but the mechanism has not been able to be explained by neither PD‐L1, TMB, nor MSI status so far.2 The gene discussed is CD274; the disease is alveolar soft part sarcoma.